UM

Browse/Search Results:  1-4 of 4 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
AAV-sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo Journal article
Cancer Letters, 2014,Volume: 354,Issue: 2,Page: 398-406
Authors:  Han L.;  Wang W.;  Lu J.;  Kong F.;  Ma G.;  Zhu Y.;  Zhao D.;  Zhu J.;  Shuai W.;  Zhou Q.;  Chen P.;  Ye L.;  Tao J.;  Ahmad S.;  Li F.;  Sun J.
Favorite | View/Download:11/0 | TC[WOS]:8 TC[Scopus]:10 | Submit date:2019/01/15
AAV  BTLA  HSP70 vaccine  Immunotherapy  Metastatic melanoma  
A novel anti-cancer agent, acetyltanshinone IIA, inhibits oestrogen receptor positive breast cancer cell growth by down-regulating the oestrogen receptor Journal article
Cancer Letters, 2014,Volume: 346,Issue: 1,Page: 94-103
Authors:  Yu T.;  Zhou Z.;  Mu Y.;  De Lima Lopes G.;  Luo K.Q.
Favorite | View/Download:5/0 | TC[WOS]:20 TC[Scopus]:24 | Submit date:2018/12/18
Acetyltanshinone Iia  Anti-breast Cancer Agent  Fulvestrant  Oestrogen Receptor  Tamoxifen  
IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities Journal article
Cancer Letters, 2013,Volume: 340,Issue: 1,Page: 88
Authors:  Li Y.-B.;  Wang Z.-Q.;  Yan X.;  Chen M.-W.;  Bao J.-L.;  Wu G.-S.;  Ge Z.-M.;  Zhou D.-M.;  Wang Y.-T.;  Li R.-T.
Favorite | View/Download:7/0 | TC[WOS]:18 TC[Scopus]:22 | Submit date:2018/10/31
Angiogenesis  Breast Cancer  Egfr  Irreversible Tki  
A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway Journal article
Cancer Letters, 2010,Volume: 297,Issue: 1,Page: 18-30
Authors:  Tian H.-L.;  Yu T.;  Xu N.-N.;  Feng C.;  Zhou L.-Y.;  Luo H.-W.;  Chang D.C.;  Le X.-F.;  Luo K.Q.
Favorite | View/Download:5/0 | TC[WOS]:37 TC[Scopus]:39 | Submit date:2018/12/18
Anticancer Drug  Apoptosis  Breast Cancer  Reactive Oxygen Species  Tanshinone Iia